The number of Risperdal lawsuits against Johnson & Johnson and Janssen nearly tripled in just six months this year. Read more
Plaintiffs have received four verdicts in their favor in Risperdal cases in Philadelphia, including a $70 million damage award. Read more
A Philadelphia jury returned a $2.5 million in damages against a Johnson & Johnson unit in the first verdict over the antipsychotic drug Risperdal’s connections to abnormal breast... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.